Smith & Nephew (SNN) Cash from Investing Activities (2009 - 2024)

Smith & Nephew (SNN) reported Cash from Investing Activities of -$360.0 million for Q4 2024, down 97.8% on a YoY basis from -$16.4 billion in Q1 2024, and down 97.8% quarter-over-quarter from -$182.0 million in Q4 2023.

Smith & Nephew (SNN) Cash from Investing Activities (2009 - 2024) Analysis & Trends

Smith & Nephew has reported Cash from Investing Activities for 16 years, with the latest figure at -$360.0 million in Q4 2024.

  • For the quarter ending Q4 2024, Cash from Investing Activities fell 97.8% year-over-year to -$360.0 million; the trailing twelve-month figure through Dec 2024 stood at -$1.2 billion (down 2.82% YoY), and the FY2025 full-year result was -$406.0 million, up 28.65% from the prior year.
  • Cash from Investing Activities for Q4 2024 stood at -$360.0 million, down from -$182.0 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was -$182.0 million in Q4 2023, with the low at -$431.0 million in Q4 2021.
  • Historically, Cash from Investing Activities has averaged -$313.4 million across 5 years, with a median of -$326.0 million in 2020.
  • Annual changes were most pronounced in 2020 — Cash from Investing Activities surged 73.94% — and 2024, when it sank 97.8%.
  • Smith & Nephew's Cash from Investing Activities stood at -$326.0 million in 2020, then sank by 32.21% to -$431.0 million in 2021, then surged by 37.82% to -$268.0 million in 2022, then jumped by 32.09% to -$182.0 million in 2023, then slumped by 97.8% to -$360.0 million in 2024.
  • The last three Cash from Investing Activities figures came in at -$360.0 million (Q4 2024), -$182.0 million (Q4 2023), and -$268.0 million (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -20.32 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -185.00 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -816.00 Mn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -92.80 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -2.50 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -475.32 Mn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -298.50 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -217.20 Mn
10 Smith & Nephew 5.34 Bn 4.77 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -360.00 Mn
Dec 31, 2024 -360.00 Mn
Dec 31, 2023 -182.00 Mn
Dec 31, 2023 -182.00 Mn
Dec 31, 2022 -268.00 Mn
Dec 31, 2022 -268.00 Mn
Dec 31, 2021 -431.00 Mn
Dec 31, 2021 -431.00 Mn
Dec 31, 2020 -326.00 Mn
Dec 31, 2020 -326.00 Mn
Dec 31, 2019 -1.25 Bn
Dec 31, 2019 -1.25 Bn
Dec 31, 2018 -378.00 Mn
Dec 31, 2018 -378.00 Mn
Dec 31, 2017 -543.00 Mn
Dec 31, 2017 -543.00 Mn
Dec 31, 2016 -383.00 Mn
Dec 31, 2016 -383.00 Mn
Dec 31, 2015 -429.00 Mn
Dec 31, 2015 -429.00 Mn